CIK: 0001351351 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value ($000): $188,386 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RED HAT INC | 255,167 | $46,619 | 24.7% | $182.70 | — | COM | 756577102 |
| CVS | CVS HEALTH CORP | 536,407 | $28,928 | 15.4% | $59.39 | -16.7% | COM | 126650100 |
| — | MELLANOX TECHNOLOGIES LTD | 195,000 | $23,080 | 12.3% | $118.36 | — | SHS | M51363113 |
| — | CELGENE CORP | 240,368 | $22,676 | 12.0% | $94.34 | — | COM | 151020104 |
| CVS | CVS HEALTH CORP | 252,900 | $13,639 | 7.2% | $59.39 | -16.7% | Call | 126650100 |
| — | CELGENE CORP | 143,100 | $13,500 | 7.2% | $94.34 | — | Put | 151020104 |
| — | INTEGRATED DEVICE TECHNOLOGY | 187,400 | $9,181 | 4.9% | $48.73 | — | COM | 458118106 |
| BMY | BRISTOL MYERS SQUIBB CO | 156,400 | $7,462 | 4.0% | — | — | Put | 110122108 |
| — | SPARK THERAPEUTICS INC | 65,000 | $7,402 | 3.9% | $113.88 | — | COM | 84652J103 |
| BMY | BRISTOL MYERS SQUIBB CO | 123,600 | $5,897 | 3.1% | — | — | Call | 110122108 |
| — | ARRIS INTERNATIONAL PLC | 157,691 | $4,985 | 2.6% | $30.72 | — | SHS | G0551A103 |
| — | ALTISOURCE ASSET MGMT CORP | 63,535 | $1,986 | 1.1% | $73.33 | — | COM | 02153X108 |
| CVS | CVS HEALTH CORP | 27,300 | $1,472 | 0.8% | $59.39 | -16.7% | Put | 126650100 |
| TAK | TAKEDA PHARMACEUTICAL CO LTD | 50,369 | $1,026 | 0.5% | $20.37 | — | SPONSORED ADS | 874060205 |
| — | MELLANOX TECHNOLOGIES LTD | 4,500 | $533 | 0.3% | $118.36 | — | Call | M51363113 |